HCA Inc: Pharmaceuticals and Healthcare Company Profile & SWOT ReportiCD ResearchFebruary 5, 2012 19 Pages - SKU: ICDR6793197 |
| Synopsis ICD Research's HCA Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's HCA Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report is a crucial resource for industry executives and anyone looking to access key information about HCA Inc.. ICD Research's HCA Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
HCA Inc. (HCA) is one of the leading health care services companies in the US. The company operates acute care, psychiatric and rehabilitation hospitals. It operates about 164 hospitals, including 158 general and acute care hospitals; five psychiatric hospitals; and one rehabilitation hospital. Its general and acute care hospitals offer a complete range of services, which include medicine, general surgery, diagnostic and emergency services, oncology, neurosurgery, cardiology, orthopedics and obstetrics. The company's psychiatric hospitals offer a range of mental health care services through inpatient, partial hospitalization and outpatient settings. Further, the company also operates about 106 freestanding surgery centers, of which nine are owned by joint ventures. Its hospitals are strategically located in Great Britain, and across 20 states in the US. HCA is headquartered in Nashville, Tennessee, the US. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

